Literature DB >> 20415627

Topical piperacillin/tazobactam for recalcitrant pseudomonas aeruginosa keratitis.

Fiona L M Chew1, T K Soong, Hoy Choong Shin, A Samsudin, Subrayan Visvaraja.   

Abstract

PURPOSE: To report the treatment of therapy-resistant Pseudomonas aeruginosa keratitis with topical piperacillin/tazobactam.
METHODS: Retrospective report of 3 cases.
RESULTS: Three patients with P. aeruginosa keratitis were unresponsive to various antimicrobials. Resolution of all 3 cases of keratitis occurred upon commencement of topical piperacillin/tazobactam.
CONCLUSION: Therapy-resistant P. aeruginosa keratitis acquired from the community is becoming an increasing problem. Topical piperacillin/tazobactam is an option for the treatment of therapy-resistant P. aeruginosa keratitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20415627     DOI: 10.1089/jop.2009.0077

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  4 in total

1.  Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.

Authors:  Samrat Chatterjee; Deepshikha Agrawal
Journal:  Indian J Ophthalmol       Date:  2016-02       Impact factor: 1.848

2.  Recalcitrant Pseudomonas Aeruginosa Keratitis with Hyphaema.

Authors:  Amy Chan; Hnin Hnin Oo; Philip Stanley; Benjamin Chang
Journal:  Case Rep Ophthalmol       Date:  2021-04-12

3.  Management and treatment of contact lens-related Pseudomonas keratitis.

Authors:  Mark Dp Willcox
Journal:  Clin Ophthalmol       Date:  2012-06-18

4.  Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.

Authors:  G Rameshkumar; R Ramakrishnan; C Shivkumar; R Meenakshi; V Anitha; Y C Venugopal Reddy; V Maneksha
Journal:  Indian J Ophthalmol       Date:  2016-04       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.